STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Conversions, 180 days
5
Codes C/M, not in net · no price filed
What the filings say about CRAI
Insiders, 180 days
-$3.1M net sold
3 sellers · 44% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$1.7M
2 notices
CRA International insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, CRA INTERNATIONAL, INC. insiders sold a net $3.1M of stock across 193 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
115 earlier Form 4 trades (code P or S) here by this insider (115 sales), the last on Jun 3, 2026.
The trade is 4.7% of the 103,850 shares held after it.
1 other insider sold within 30 days.
Insider activity: PRESIDENT AND CEO Maleh Paul A sold about $839.6K of CRAI under a 10b5-1 plan on Aug 31, 2026, the largest insider sale at the company since 2025; 1 other insider sold within 30 days.
36 earlier Form 4 trades (code P or S) here by this insider (36 sales), the last on May 19, 2026.
The trade is 4.2% of the 12,860 shares held after it.
1 other insider sold within 30 days.
Insider activity: EVP AND GENERAL COUNSEL Yellin Jonathan D sold about $93.6K of CRAI under a 10b5-1 plan on Aug 25, 2026; 1 other insider sold within 30 days.
193 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
CRAI planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Paul A. Maleh
Filed 2026-08-31
$1.3M
Jonathan D. Yellin
Filed 2026-08-25
$389.8K
Heather Tookes
Filed 2026-07-23
$14.6K
Heather Tookes
Filed 2026-07-16
$21.5K
Executive pay vs shareholder return · Mr. Maleh
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$3.6M
$1.7M
$1.2M
+96%
+56%
2022
$3.8M
$6.7M
$1.3M
+140%
+39%
2021
$3.8M
$8.7M
$1.2M
+80%
+41%
2020
$3.7M
$3.4M
$1.3M
-3%
+10%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $3.1M sold by insiders over 180 days, $1.7M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$794.6M
four quarters, 2025-06-29 to 2026-07-04
Revenue, TTM CRAI
FY Jan 2026
$751.6M
FY Dec 2024
$687.4M
FY Dec 2023
$624.0M
FY Dec 2022
$590.9M
FY Jan 2022
$565.9M
Jul 2026
$210.8M
Apr 2026
$201.0M
Jan 2026
$197.0M
Sep 2025
$185.9M
Jun 2025
$186.9M
Mar 2025
$181.9M
Dec 2024
$176.4M
Sep 2024
$167.7M
At each fiscal year end
Single quarter
Net margin, TTM
+6.2%
net income over revenue, 2025-06-29 to 2026-07-04
Net margin, TTM CRAI
FY Jan 2026
+7.3%
FY Dec 2024
+6.8%
FY Dec 2023
+6.2%
FY Dec 2022
+7.4%
FY Jan 2022
+7.4%
Jul 2026
+6.4%
Apr 2026
+5.5%
Jan 2026
+6.7%
Sep 2025
+6.2%
Jun 2025
+6.5%
Mar 2025
+9.9%
Dec 2024
+8.5%
Sep 2024
+6.8%
At each fiscal year end
Single quarter
Free cash flow, TTM
-$27.7M
operating cash flow minus capex, 2025-06-29 to 2026-07-04
Free cash flow, TTM CRAI
FY Jan 2026
$18.6M
FY Dec 2024
$33.1M
FY Dec 2023
$57.7M
FY Dec 2022
$21.3M
FY Jan 2022
$73.1M
Jul 2026
-$6.1M
Apr 2026
-$116.5M
Jan 2026
$59.0M
Sep 2025
$35.9M
Jun 2025
$4.7M
Mar 2025
-$81.0M
Dec 2024
$68.8M
Sep 2024
$28.6M
At each fiscal year end
Single quarter
Debt to equity
0.03x
current debt only, 2018-09-29 (94 months older than the period end); equity 2026-07-04
Debt to equity CRAI
FY Jan 2026
0.02x
FY Dec 2024
0.02x
FY Dec 2023
0.02x
FY Dec 2022
0.02x
FY Jan 2022
0.02x
Jul 2026
0.03x
Apr 2026
0.03x
Jan 2026
0.02x
Sep 2025
0.02x
Jun 2025
0.03x
Mar 2025
0.02x
Dec 2024
0.02x
Sep 2024
0.02x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-4.35x
TTM operating cash flow over current debt only, 2018-09-29 (94 months older than the period end)
Cash flow to debt CRAI
FY Jan 2026
4.48x
FY Dec 2024
9.95x
FY Dec 2023
12.01x
FY Dec 2022
5.02x
FY Jan 2022
15.14x
Jul 2026
-4.35x
Apr 2026
-2.29x
Jan 2026
4.48x
Sep 2025
8.37x
Jun 2025
7.37x
Mar 2025
6.56x
Dec 2024
9.95x
Sep 2024
6.08x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+26.0%
TTM net income over average of 2025-06-28 and 2026-07-04
Return on equity CRAI
FY Jan 2026
+25.7%
FY Dec 2024
+22.0%
FY Dec 2023
+18.2%
FY Dec 2022
+20.9%
FY Jan 2022
+20.1%
Jul 2026
+26.0%
Apr 2026
+22.5%
Jan 2026
+25.7%
Sep 2025
+27.9%
Jun 2025
+29.1%
Mar 2025
+23.2%
Dec 2024
+22.0%
Sep 2024
+20.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+7.7%
TTM net income over average of 2025-06-28 and 2026-07-04
Return on assets CRAI
FY Jan 2026
+9.1%
FY Dec 2024
+8.3%
FY Dec 2023
+7.0%
FY Dec 2022
+7.9%
FY Jan 2022
+7.5%
Jul 2026
+7.7%
Apr 2026
+7.7%
Jan 2026
+9.1%
Sep 2025
+9.3%
Jun 2025
+9.8%
Mar 2025
+8.9%
Dec 2024
+8.3%
Sep 2024
+7.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+31.1%
operating income after a 31.8% effective tax rate, over current debt only, 2018-09-29 (94 months older than the period end) plus average of 2025-06-28 and 2026-07-04 minus cash
Return on invested capital CRAI
FY Jan 2026
+30.4%
FY Dec 2024
+27.5%
FY Dec 2023
+23.8%
FY Dec 2022
+26.5%
FY Jan 2022
+27.3%
Jul 2026
+31.1%
Apr 2026
+27.7%
Jan 2026
+30.4%
Sep 2025
+32.3%
Jun 2025
+34.2%
Mar 2025
+28.1%
Dec 2024
+27.5%
Sep 2024
+25.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+28.7%
operating income (EBIT proxy) over average of 2025-06-28 and 2026-07-04 minus current liabilities
Return on capital employed CRAI
FY Jan 2026
+26.9%
FY Dec 2024
+22.2%
FY Dec 2023
+17.7%
FY Dec 2022
+17.4%
FY Jan 2022
+15.9%
Jul 2026
+28.7%
Apr 2026
+25.1%
Jan 2026
+26.9%
Sep 2025
+27.8%
Jun 2025
+29.2%
Mar 2025
+24.1%
Dec 2024
+22.2%
Sep 2024
+21.1%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
P/E, trailing CRAI
FY Jan 2026
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Jan 2022
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$1.2B
market value at close 2026-10-26 on 2026-07-31 shares, plus current debt only, 2018-09-29 (94 months older than the period end), minus cash 2026-07-04
Enterprise value CRAI
FY Jan 2026
$1.3B
FY Dec 2024
$1.2B
FY Dec 2023
$651.5M
FY Dec 2022
$847.1M
FY Jan 2022
$632.3M
Jul 2026
$932.3M
Apr 2026
$1.1B
Jan 2026
$1.3B
Sep 2025
$1.3B
Jun 2025
$1.3B
Mar 2025
$1.2B
Dec 2024
$1.2B
Sep 2024
$1.1B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-2.2%
TTM free cash flow over market value at close 2026-10-26
FCF yield CRAI
FY Jan 2026
+1.4%
FY Dec 2024
+2.6%
FY Dec 2023
+8.3%
FY Dec 2022
+2.4%
FY Jan 2022
+10.5%
Jul 2026
-2.9%
Apr 2026
-1.6%
Jan 2026
+1.4%
Sep 2025
+2.1%
Jun 2025
+1.7%
Mar 2025
+1.4%
Dec 2024
+2.6%
Sep 2024
+2.1%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
PEG, trailing CRAI
FY Jan 2026
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Jan 2022
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CRAI ranks highest on profitability (84th percentile) and risk and compliance (62nd), and lowest on insider conviction (19th), among Services peers.
Profitability
84
Inputs
Return on equity+26.0% · 82 pct, sector of 207
Return on assets+7.7% · 78 pct, sector of 269
Return on invested capital+31.1% · 82 pct, sector of 81
Return on capital employed+28.7% · 93 pct, sector of 203
Financial health
43
Inputs
Debt to equity0.03x · 80 pct, sector of 228
Cash flow to debt-4.35x · 6 pct, sector of 199
Growth
61
Inputs
Revenue growth, YoY+9.3% · 61 pct, sector of 341
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
19
Inputs
Net Form 4 buying (codes P and S), 180d-$1.4M · 39 pct, sector of 174
Insider buyers, 180d0 · 0 pct, sector of 179
Risk and compliance
62
Inputs
Short interest, % of float+4.8% · 36 pct, sector of 383
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+3.8% · 88 pct, sector of 227
2 not measured: Institutional and government, US patents
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CRAI filings, in plain words
Are CRA International insiders buying or selling CRAI?
In the 180 days to 2026-10-28, CRA International insiders were net sellers, a net $3.1M across purchases and sales reported on Form 4, by 3 sellers.
Are there planned insider sales of CRAI?
Yes. 2 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $1.7M of stock; the latest, by Paul A. Maleh, was filed 2026-08-31.
Read the full summary
In the 180 days to 2026-10-28, CRA International insiders were net sellers of CRAI, a net $3.1M across purchases and sales reported on Form 4 by 3 sellers. 44% of the 16 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 2 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $1.7M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.